18:50Web3 0 + New Frontiers in Cancer and Longevity Research: VitaDAO’s DeSci Initiative16:00Press Release 0 + Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
16:00Press Release 0 + Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
